March 06, 2009 -- Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals International , announced today the commercial launch of Acanya(TM) Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) indicated for the once-daily treatment of acne vulgaris in patients 12 years and older.
The details can be read here.
No comments:
Post a Comment